Early clinical studies to explore candidate biomarkers in targeted cancer therapies
PhD ceremony: Ms. C.N.A.M. Oldenhuis, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Early clinical studies to explore candidate biomarkers in targeted cancer therapies
Promotor(s): prof. J.A. Gietema, prof. E.G.E. de Vries, prof. S. de Jong
Faculty: Medical Sciences
Currently, much information is becoming available from tumor cell biology research, opening opportunities for the development of specifically tumor targeting agents. In this thesis we studied the safety, tolerability and pharmacokinetics of two novel targeted agents in phase 1 studies. An oral angiogenesis inhibitor and the apoptosis inducing agonistic antibody mapatumumab both appeared safe in combination with chemotherapy. No pharmacokinetic interactions were seen. Further studies on this combination are therefore warranted.
Last modified: | 13 March 2020 01.02 a.m. |
More news
-
10 June 2024
Swarming around a skyscraper
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
06 June 2024
Wiro Niessen Captain of Science of Top Sector Life Sciences & Health
Wiro Niessen, dean of the Faculty of Medical Sciences, has been appointed Captain of Science of the Top Team of the Top Sector Life Sciences & Health (LSH) by Minister Adriaansens of Economic Affairs and Climate. His appointment is effective 1 June...
-
29 May 2024
European joint Master’s degree programmes are among the top programmes
On 27 May, the EACEA in Brussels celebrated the fact that the first Erasmus Mundus Master’s degree programmes were launched twenty years ago.